In fact, the difference was marginal in the critical range of ~0–10% AFP-L3, especially with <2.0% (Fig. 5d), where a slight difference in %AFP-L3 could affect the diagnostic decisions on the risk of HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.